Is hepatitis C treatable post kidney transplant?
Yes. Interferon alpha and ribavirin are contraindicated post transplant. Direct-acting antiviral agents (DAAs) can be used in the kidney transplant population with an estimated glomerular filtration rate >30 mL/min.
This has also increased the use of hepatitis C–positive kidneys in transplantation, increasing the transplant rate. A patient with hepatitis C, if not overtly cirrhotic, can be listed for a hepatitis C kidney, which has a substantially shorter wait time.
They are treated post transplant with DAAs. Studies are being developed to look at transplanting organs from Hepatitis C positive donors to hepatitis C negative recipients. The recipients would be treated for Hepatitis C posttransplant.
